Complementing Ceram’s existing non-biological materials testing capabilities, the new microbiology testing service means that medical device, pharmaceutical and consumer healthcare manufacturers will be able to get all their testing done by one supplier.
In addition to routine bioburden determination, endotoxin/LAL testing and sterility testing and validation, Ceram’s suite of tests also include anti-microbial efficacy testing, cleanroom monitoring and cleaning/disinfectant validation for reusable devices.
Gemma Budd, Product Manager for Healthcare at Ceram, says: “Adding microbiology testing to our portfolio means that we are quite unique in offering a chemical, physical, surface and microbiological analysis service. What’s more, we don’t just provide testing for QA/QC and regulatory approval – our materials expertise means that we provide analysis and, most importantly, solutions. So, whether there is an issue with a product failing or whether R&D support for new product development is needed, such as for anti-microbial product claims, our comprehensive testing capability means that we can help.”
To find out more about Ceram’s microbiology testing services visit www.ceram.com/microbiology.
